Free Trial

Nuveen Asset Management LLC Has $29.12 Million Stake in Avantor, Inc. (NYSE:AVTR)

Avantor logo with Medical background

Nuveen Asset Management LLC cut its stake in Avantor, Inc. (NYSE:AVTR - Free Report) by 7.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,381,854 shares of the company's stock after selling 105,272 shares during the period. Nuveen Asset Management LLC owned about 0.20% of Avantor worth $29,116,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. MassMutual Private Wealth & Trust FSB raised its holdings in shares of Avantor by 99.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company's stock worth $26,000 after buying an additional 625 shares in the last quarter. Smartleaf Asset Management LLC raised its holdings in shares of Avantor by 106.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company's stock worth $34,000 after buying an additional 830 shares in the last quarter. Global Retirement Partners LLC raised its holdings in shares of Avantor by 76.7% in the 4th quarter. Global Retirement Partners LLC now owns 2,459 shares of the company's stock worth $52,000 after buying an additional 1,067 shares in the last quarter. UMB Bank n.a. raised its holdings in shares of Avantor by 56.3% in the 4th quarter. UMB Bank n.a. now owns 2,981 shares of the company's stock worth $63,000 after buying an additional 1,074 shares in the last quarter. Finally, AlphaQuest LLC acquired a new position in shares of Avantor in the 4th quarter worth approximately $65,000. 95.08% of the stock is owned by institutional investors and hedge funds.

Avantor Trading Up 3.6%

AVTR stock traded up $0.46 during midday trading on Tuesday, hitting $13.15. 13,271,512 shares of the company's stock were exchanged, compared to its average volume of 7,933,383. The stock's fifty day moving average price is $14.29 and its 200-day moving average price is $18.12. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.70 and a current ratio of 1.07. The company has a market cap of $8.96 billion, a PE ratio of 12.64, a price-to-earnings-growth ratio of 1.55 and a beta of 1.09. Avantor, Inc. has a one year low of $11.82 and a one year high of $28.00.

Avantor (NYSE:AVTR - Get Free Report) last issued its quarterly earnings results on Friday, April 25th. The company reported $0.23 EPS for the quarter, meeting analysts' consensus estimates of $0.23. Avantor had a return on equity of 12.17% and a net margin of 10.49%. The company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.61 billion. During the same period in the previous year, the company posted $0.22 earnings per share. The company's quarterly revenue was down 5.9% compared to the same quarter last year. Research analysts predict that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, CAO Steven W. Eck sold 4,907 shares of the company's stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $86,019.71. Following the transaction, the chief accounting officer now owns 40,604 shares of the company's stock, valued at approximately $711,788.12. This represents a 10.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP James Bramwell sold 3,758 shares of the company's stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total value of $65,877.74. Following the completion of the transaction, the executive vice president now directly owns 87,379 shares in the company, valued at $1,531,753.87. The trade was a 4.12% decrease in their position. The disclosure for this sale can be found here. Insiders have acquired a total of 83,100 shares of company stock valued at $1,027,630 over the last 90 days. 1.20% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

AVTR has been the subject of a number of recent research reports. Morgan Stanley cut Avantor from an "overweight" rating to an "equal weight" rating in a report on Tuesday, April 29th. TD Cowen cut Avantor from a "buy" rating to a "hold" rating and set a $15.50 price target for the company. in a report on Monday, April 28th. The Goldman Sachs Group cut Avantor from a "buy" rating to a "neutral" rating and dropped their price target for the company from $23.00 to $14.00 in a report on Tuesday, April 29th. Stifel Nicolaus cut Avantor from a "buy" rating to a "hold" rating and dropped their price target for the company from $26.00 to $14.00 in a report on Monday, April 28th. Finally, Citigroup dropped their price target on Avantor from $22.00 to $18.00 and set a "neutral" rating for the company in a report on Tuesday, March 4th. Seven analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, Avantor presently has an average rating of "Hold" and a consensus target price of $18.88.

Get Our Latest Research Report on Avantor

Avantor Profile

(Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Recommended Stories

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Should You Invest $1,000 in Avantor Right Now?

Before you consider Avantor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.

While Avantor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Tech Stocks Insiders Are Buying: Speculative Plays for June
3 Defense Stocks Set to Crush the S&P This Summer
Analysts Are Watching These 4 Penny Stocks—You Should Too

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines